The prevalence of PHPT varies by age and sex. Women are more commonly affected than men, with a peak incidence between 50 and 60 years of age.1 The annual incidence among patients younger than 40 years is reportedly less than 10 per 100 000.2 In a young patient, the findings might also represent skeletal manifestations of a genetic disease, such as polyostotic fibrous dysplasia in the setting of McCune-Albright syndrome. Parathyroid hormone induces serum calcium by stimulating the release of calcium from bone matrix, increasing calcium and decreasing phosphate reabsorption by the kidney, and indirectly facilitating calcium absorption from the small intestine by stimulating renal production of 1,25-dihydroxyvitamin D.3 Primary hyperparathyroidism is usually caused by a parathyroid adenoma and less frequently by hyperplasia or carcinoma. The excess PTH secretion leads to hypercalcemia in the absence of significant renal dysfunction, thus resulting in the symptoms and signs summarized by the mnemonic “stones, bones, abdominal groans, and psychiatric moans,” which refers to nephrolithiasis, bone-related complications, gastrointestinal symptoms, and effects on the central nervous system. Serum phosphorus levels are commonly low in PHPT due to the phosphaturic effect of PTH on the kidney. Moderate anemia may be seen in severe PHPT. The etiology for the anemia remains unknown; however, marrow fibrosis is thought to play a key role because it is common in such patients and has been seen to improve after parathyroidectomy.4